Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs
Open Access
- 1 October 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 119 (3) , 609-615
- https://doi.org/10.1111/j.1476-5381.1996.tb15716.x
Abstract
The distribution of cardiac output during administration of levosimendan, a new myofilament calcium sensitizer, is unknown. We examined and compared the effects of levosimendan, pimobendan, and milrinone on regional tissue perfusion by use of the radioactive microsphere technique in barbiturate‐anaesthetized dogs. Haemodynamics and regional blood flow were determined before and during infusions of levosimendan (0.75, 1.5, and 3.0 μg kg−1 min−1), pimobendan (10, 20, and 40 μg kg−1 min−1), or milrinone (1.0, 2.0, and 4.0 μg kg−1 min−1). All three drugs caused similar increases in heart rate, cardiac output, and left ventricular + dP/dt and decreases in end‐diastolic pressure and systemic vascular resistance. No changes in subendocardial, midmyocardial, and subepicardial blood flow occurred during administration of levosimendan. However, a redistribution of blood flow from subendocardium to subepicardium was observed. Pimobendan increased midmyocardial and subepicardial blood flow and reduced the endo/epi ratio to a greater degree than levosimendan. Milrinone did not affect myocardial perfusion. Levosimendan increased blood flow to the renal medulla and decreased renal medullary and cortical vascular resistance. Levosimendan increased blood flow to the small intestine and liver and reduced vascular resistance in these organs. Pimobendan increased hepatic blood flow to a greater degree than levosimendan but did not alter small intestinal perfusion. All three drugs decreased splenic blood flow to similar degrees. Levosimendan and pimobendan reduced cerebral vascular resistance. Levosimendan and milrinone reduced skeletal muscle vascular resistance. The results indicate that levosimendan, pimobendan, and milrinone cause subtlety different alterations in regional tissue perfusion while producing similar haemodynamic effects.Keywords
This publication has 35 references indexed in Scilit:
- Systemic and Coronary Hemodynamic Actions and Left Ventricular Functional Effects of Levosimendan in Conscious DogsJournal of Cardiovascular Pharmacology, 1995
- Hemodynamic and neurohumoral effects of levosimedan, a new calcium sensitizer, at rest and during exercise in healthy menThe American Journal of Cardiology, 1995
- Dose-Range Study of a New Calcium Sensitizer, Levosimendan, in Patients with Left Ventricular DysfunctionJournal of Cardiovascular Pharmacology, 1995
- Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathyAmerican Heart Journal, 1989
- Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1989
- Central and Regional Vascular Hemodynamics Following Intravenous Milrinone in the Conscious RatJournal of Cardiovascular Pharmacology, 1987
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac diseaseThe American Journal of Cardiology, 1985
- Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.Circulation, 1984
- Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dogCanadian Journal of Physiology and Pharmacology, 1982